272 related articles for article (PubMed ID: 16968909)
21. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
22. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?
Hamel MJ; Greene C; Chiller T; Ouma P; Polyak C; Otieno K; Williamson J; Shi YP; Feikin DR; Marston B; Brooks JT; Poe A; Zhou Z; Ochieng B; Mintz E; Slutsker L
Am J Trop Med Hyg; 2008 Sep; 79(3):320-30. PubMed ID: 18784222
[TBL] [Abstract][Full Text] [Related]
23. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
25. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
Mayor A; Serra-Casas E; Sanz S; Aponte JJ; Macete E; Mandomando I; Puyol L; Berzosa P; Dobaño C; Aide P; Sacarlal J; Benito A; Alonso P; Menéndez C
J Infect Dis; 2008 Jun; 197(12):1737-42. PubMed ID: 18419347
[TBL] [Abstract][Full Text] [Related]
26. Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.
Basco LK; Tahar R; Keundjian A; Ringwald P
J Infect Dis; 2000 Aug; 182(2):624-8. PubMed ID: 10915101
[TBL] [Abstract][Full Text] [Related]
27. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
28. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
[TBL] [Abstract][Full Text] [Related]
29. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
Shah SN; Smith EE; Obonyo CO; Kain KC; Bloland PB; Slutsker L; Hamel MJ
J Infect Dis; 2006 Dec; 194(11):1519-28. PubMed ID: 17083036
[TBL] [Abstract][Full Text] [Related]
30. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
Tinto H; Ouédraogo JB; Zongo I; van Overmeir C; van Marck E; Guiguemdé TR; D'Alessandro U
Am J Trop Med Hyg; 2007 Apr; 76(4):608-13. PubMed ID: 17426157
[TBL] [Abstract][Full Text] [Related]
31. [Molecular surveillance of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in São Tomé and Príncipe].
Tahar R; Djaman J; Ferreira C; Basco L
Bull Soc Pathol Exot; 2007 May; 100(2):115-8. PubMed ID: 17727034
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
[TBL] [Abstract][Full Text] [Related]
33. Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine.
Marks F; von Kalckreuth V; Kobbe R; Adjei S; Adjei O; Horstmann RD; Meyer CG; May J
J Infect Dis; 2005 Dec; 192(11):1962-5. PubMed ID: 16267768
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda.
Sendagire H; Kyabayinze D; Swedberg G; Kironde F
Trop Med Int Health; 2005 Jun; 10(6):537-43. PubMed ID: 15941416
[TBL] [Abstract][Full Text] [Related]
35. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.
Staedke SG; Sendagire H; Lamola S; Kamya MR; Dorsey G; Rosenthal PJ
Trop Med Int Health; 2004 May; 9(5):624-9. PubMed ID: 15117308
[TBL] [Abstract][Full Text] [Related]
36. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
Ndounga M; Tahar R; Basco LK; Casimiro PN; Malonga DA; Ntoumi F
Trop Med Int Health; 2007 Oct; 12(10):1164-71. PubMed ID: 17956498
[TBL] [Abstract][Full Text] [Related]
38. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
[TBL] [Abstract][Full Text] [Related]
39. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.
Thapa S; Hollander J; Linehan M; Cox-Singh J; Bista MB; Thakur GD; Davis WA; Davis TM
Am J Trop Med Hyg; 2007 Sep; 77(3):423-30. PubMed ID: 17827354
[TBL] [Abstract][Full Text] [Related]
40. Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine.
Gatton ML; Cheng Q
J Antimicrob Chemother; 2006 Jul; 58(1):47-51. PubMed ID: 16641113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
